EMPAGLIFLOZINA 10 MG COM REV CT BL AL PLAS PVC TRANS X 30
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1256803910022 -
GGREM
528526080262607 -
Código de barras
7899547555042 -
Código de barras
7899547555059
O que a fonte publica
- Detentor do registro
- PRATI DONADUZZI & CIA LTDA
- Princípios ativos
- EMPAGLIFLOZINA
- Embalagem
- 10 MG COM REV CT BL AL PLAS PVC TRANS X 30
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Genérico
- Classe terapêutica
- A10P1 - ANTIDIABÉTICOS INIBIDORES DE SGLT2, PUROS
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "EMPAGLIFLOZINA 10 MG COM REV CT BL AL PLAS PVC TRANS X 30",
"holder": "PRATI DONADUZZI & CIA LTDA",
"stripe": "Tarja Vermelha",
"barcodes": [
"7899547555042",
"7899547555059"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "528526080262607",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "73.856.593/0001-66",
"priceRegime": "Regulado",
"productName": "EMPAGLIFLOZINA",
"productType": "Genérico",
"hospitalOnly": false,
"presentation": "10 MG COM REV CT BL AL PLAS PVC TRANS X 30",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "129.11",
"icms-12": "146.72",
"icms-17": "155.55",
"icms-18": "157.45",
"icms-19": "159.40",
"icms-20": "161.39",
"icms-21": "163.43",
"icms-22": "165.53",
"icms-23": "167.68",
"icms-17.5": "156.50",
"icms-19.5": "160.39",
"icms-20.5": "162.40",
"icms-22.5": "166.59",
"icms-12-alc": "131.00",
"icms-17-alc": "138.89",
"icms-18-alc": "140.58",
"icms-19-alc": "142.32",
"icms-20-alc": "144.10",
"icms-21-alc": "145.92",
"icms-22-alc": "147.79",
"icms-23-alc": "149.71",
"withoutTaxes": "115.28",
"icms-17.5-alc": "139.73",
"icms-19.5-alc": "143.20",
"icms-20.5-alc": "145.00",
"icms-22.5-alc": "148.74"
},
"pisCofinsList": "Negativa",
"substanceText": "EMPAGLIFLOZINA",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "173.20",
"icms-12": "196.82",
"icms-17": "208.66",
"icms-18": "211.21",
"icms-19": "213.83",
"icms-20": "216.50",
"icms-21": "219.24",
"icms-22": "222.05",
"icms-23": "224.94",
"icms-17.5": "209.94",
"icms-19.5": "215.16",
"icms-20.5": "217.85",
"icms-22.5": "223.47",
"icms-12-alc": "181.10",
"icms-17-alc": "192.01",
"icms-18-alc": "194.34",
"icms-19-alc": "196.75",
"icms-20-alc": "199.21",
"icms-21-alc": "201.73",
"icms-22-alc": "204.31",
"icms-23-alc": "206.97",
"withoutTaxes": "159.36",
"icms-17.5-alc": "193.17",
"icms-19.5-alc": "197.97",
"icms-20.5-alc": "200.45",
"icms-22.5-alc": "205.62"
},
"invalidBarcodes": [],
"activeSubstances": [
"EMPAGLIFLOZINA"
],
"therapeuticClass": "A10P1 - ANTIDIABÉTICOS INIBIDORES DE SGLT2, PUROS",
"commercialisation": {
"year": 2025,
"marketed": false
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1256803910022",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "A10P1",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:528526080262607"